GenMont Biotech (3164.TW) Stock Price

GenMont Biotech Price

CLOSED
16.55TWD-0.10 (-0.60 %)
Market closed

Over the last 19 years GenMont Biotech grew revenue by 4.6% annually, reaching 401.23 M TWD. Earnings per share have declined at 8.5% per year over the last 15 years. For GenMont Biotech, the net margin of 14.3% is down versus 26.4% a few years ago. At today's price the dividend yield works out to roughly 4.83%. The payout ratio is around 110% of earnings. The dividend has grown at 1.7% per year over the past 17 years. The stock trades about 4% above its 52-week low.

GenMont Biotech stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of GenMont Biotech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how GenMont Biotech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing GenMont Biotech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

GenMont Biotech Stock Price History
DateGenMont Biotech Price
8/11/202616.55 TWD
8/10/202616.65 TWD
8/7/202616.40 TWD
8/6/202616.30 TWD
8/5/202616.20 TWD
8/4/202616.15 TWD
8/3/202616.25 TWD
7/31/202616.35 TWD
7/30/202616.30 TWD
7/29/202616.45 TWD
7/28/202616.30 TWD
7/27/202616.55 TWD
7/24/202616.40 TWD
7/23/202616.10 TWD
7/22/202616.25 TWD
7/21/202616.35 TWD
7/20/202616.15 TWD
7/17/202616.30 TWD
7/16/202616.50 TWD
7/15/202616.60 TWD
7/14/202616.50 TWD
7/13/202616.40 TWD
7/10/202616.45 TWD
7/9/202616.45 TWD
7/8/202616.55 TWD
7/7/202616.50 TWD
7/6/202616.50 TWD
7/3/202616.30 TWD
7/2/202616.05 TWD
7/1/202615.95 TWD
6/30/202615.90 TWD
6/29/202615.95 TWD
6/26/202615.90 TWD
6/25/202616.15 TWD
6/24/202616.25 TWD
6/23/202616.30 TWD
6/22/202616.30 TWD
6/18/202616.40 TWD
6/17/202616.40 TWD
6/16/202616.40 TWD
6/15/202616.40 TWD
6/12/202616.35 TWD
6/11/202616.35 TWD
6/10/202616.35 TWD
6/9/202616.40 TWD
6/8/202617.25 TWD
6/5/202616.55 TWD
6/4/202616.40 TWD
6/3/202616.50 TWD
6/2/202616.35 TWD
6/1/202616.40 TWD
5/29/202616.55 TWD
5/28/202616.60 TWD
5/27/202616.20 TWD
5/26/202616.35 TWD
5/25/202616.45 TWD
5/22/202616.50 TWD
5/21/202616.70 TWD
5/20/202617.00 TWD
5/19/202616.80 TWD
5/18/202616.90 TWD
5/15/202617.05 TWD
5/14/202617.20 TWD
5/13/202617.30 TWD
5/12/202617.60 TWD
5/11/202617.60 TWD
5/8/202617.40 TWD
5/7/202617.50 TWD
5/6/202617.60 TWD
5/5/202617.70 TWD
5/4/202617.70 TWD
4/30/202617.70 TWD
4/29/202617.75 TWD
4/28/202617.95 TWD
4/27/202617.90 TWD
4/24/202617.85 TWD
4/23/202617.70 TWD
4/22/202617.90 TWD
4/21/202618.00 TWD
4/20/202618.05 TWD
4/17/202617.95 TWD
4/16/202617.95 TWD
4/15/202618.00 TWD
4/14/202617.95 TWD
4/13/202617.90 TWD
4/10/202617.80 TWD
4/9/202617.85 TWD
4/8/202618.00 TWD
4/7/202618.70 TWD
4/2/202618.35 TWD
4/1/202618.50 TWD
3/31/202618.10 TWD
3/30/202618.40 TWD
3/27/202618.50 TWD
3/26/202618.30 TWD
3/25/202618.25 TWD
3/24/202617.95 TWD
3/23/202618.00 TWD
3/20/202618.25 TWD
3/19/202618.50 TWD
3/18/202618.50 TWD
3/17/202618.30 TWD
3/16/202618.10 TWD
3/13/202618.15 TWD
3/12/202618.05 TWD
3/11/202618.10 TWD
3/10/202618.05 TWD
3/9/202617.55 TWD
3/6/202617.95 TWD
3/5/202617.95 TWD
2/26/202617.80 TWD
2/25/202617.90 TWD
2/24/202618.15 TWD
2/23/202617.95 TWD
2/11/202617.75 TWD
2/10/202617.70 TWD
2/9/202617.85 TWD
2/6/202617.95 TWD
2/5/202617.95 TWD
2/4/202618.00 TWD
2/3/202617.95 TWD
2/2/202618.05 TWD
1/30/202618.25 TWD
1/29/202618.15 TWD
1/28/202618.45 TWD
1/27/202618.20 TWD
1/26/202618.10 TWD
1/23/202618.45 TWD
1/22/202618.10 TWD
1/21/202618.00 TWD
1/20/202618.00 TWD
1/19/202618.05 TWD
1/16/202618.05 TWD
1/15/202618.25 TWD
1/14/202618.20 TWD
1/13/202618.15 TWD
1/12/202618.25 TWD
1/8/202618.45 TWD
1/7/202618.05 TWD
1/6/202618.10 TWD
1/5/202618.10 TWD
1/2/202618.30 TWD
12/31/202518.35 TWD
12/30/202518.20 TWD
12/29/202518.20 TWD
12/26/202518.30 TWD
12/24/202518.35 TWD
12/23/202518.20 TWD
12/22/202518.30 TWD
12/19/202518.25 TWD
12/18/202518.30 TWD
12/17/202518.15 TWD
12/16/202518.20 TWD
12/15/202518.30 TWD
12/12/202518.25 TWD
12/11/202518.35 TWD
12/10/202518.35 TWD
12/9/202518.50 TWD
12/8/202518.55 TWD
12/5/202518.45 TWD
12/4/202518.40 TWD
12/3/202518.50 TWD
12/2/202518.50 TWD
12/1/202518.50 TWD
11/28/202518.60 TWD
11/27/202518.60 TWD
11/26/202518.60 TWD
11/25/202518.40 TWD
11/24/202518.35 TWD
11/21/202518.30 TWD
11/20/202518.55 TWD
11/19/202518.35 TWD
11/18/202518.60 TWD
11/17/202518.70 TWD
11/14/202518.50 TWD
11/13/202518.50 TWD
11/12/202518.50 TWD
11/11/202518.30 TWD
11/10/202518.60 TWD
11/7/202518.50 TWD
11/6/202518.50 TWD
11/5/202518.40 TWD
11/4/202518.60 TWD
11/3/202518.55 TWD
10/31/202518.60 TWD
10/30/202518.70 TWD
10/29/202518.80 TWD
10/28/202518.75 TWD
10/27/202519.00 TWD
10/23/202518.90 TWD
10/22/202519.10 TWD
10/21/202518.95 TWD
10/20/202518.90 TWD
10/17/202519.05 TWD
10/16/202519.10 TWD
10/15/202519.00 TWD
10/14/202518.80 TWD
10/13/202518.95 TWD
10/9/202519.05 TWD
10/8/202519.15 TWD
10/7/202519.30 TWD
10/3/202519.25 TWD
10/2/202518.90 TWD
10/1/202519.00 TWD
9/30/202519.15 TWD
9/26/202519.15 TWD
9/25/202519.25 TWD
9/24/202519.20 TWD
9/23/202519.35 TWD
9/22/202519.45 TWD
9/19/202519.50 TWD
9/18/202519.70 TWD
9/17/202519.55 TWD
9/16/202519.75 TWD
9/15/202519.75 TWD
9/12/202519.80 TWD
9/11/202519.95 TWD
9/10/202520.30 TWD
9/9/202520.30 TWD
9/8/202520.10 TWD
9/5/202520.15 TWD
9/4/202520.00 TWD
9/3/202519.60 TWD
9/2/202519.50 TWD
9/1/202519.60 TWD
8/29/202519.65 TWD
8/28/202519.60 TWD
8/27/202519.70 TWD
8/26/202519.75 TWD
8/25/202519.80 TWD
8/22/202519.75 TWD
8/21/202519.80 TWD
8/20/202519.60 TWD
8/19/202519.90 TWD
8/18/202519.80 TWD
8/15/202519.95 TWD
8/14/202519.75 TWD
Access this data via the Eulerpool API
Get Free API Key

GenMont Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
406.53 M TWD
122.82 M TWD
158.02 M TWD
Jan 1, 2019
346.24 M TWD
76.77 M TWD
57.45 M TWD
Jan 1, 2020
325.19 M TWD
77.00 M TWD
60.88 M TWD
Jan 1, 2021
427.93 M TWD
143.49 M TWD
113.13 M TWD
Jan 1, 2022
368.55 M TWD
60.18 M TWD
56.98 M TWD
Jan 1, 2023
318.02 M TWD
6.99 M TWD
32.99 M TWD
Jan 1, 2024
385.37 M TWD
40.12 M TWD
57.25 M TWD
Jan 1, 2025
401.23 M TWD
57.75 M TWD
57.20 M TWD

GenMont Biotech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 13, 2026, 7:44 AM
 
REVENUEM TWD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM TWD
EBITM TWD
EBIT MARGIN%
NET INCOMEM TWD
NET INCOME GROWTH%
DIV.TWD
DIV. GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
514.00286.00226.00308.00564.00534.00540.00380.00406.00346.00325.00427.00368.00318.00385.00401.00
46.02-44.36-20.9836.2883.12-5.321.12-29.636.84-14.78-6.0731.38-13.82-13.5921.074.16
76.4666.7863.7269.4844.8651.1257.4169.4768.2366.1866.1570.0269.5766.3561.8262.59
393.00191.00144.00214.00253.00273.00310.00264.00277.00229.00215.00299.00256.00211.00238.00251.00
156.00-16.00-29.0056.00-144.00-45.00-18.00109.00122.0076.0076.00143.0060.006.0040.0057.00
30.35-5.59-12.8318.18-25.53-8.43-3.3328.6830.0521.9723.3833.4916.301.8910.3914.21
147.0038.0028.0030.00-386.00-98.00-235.0045.00158.0057.0060.00113.0056.0032.0057.0057.00
70.93-74.15-26.327.14-1,386.67-74.61139.80-119.15251.11-63.925.2688.33-50.44-42.8678.13–
0.912.001.000.50–––––1.500.800.57–0.700.500.80
-9.00119.78-50.00-50.00––––––-46.67-28.75––-28.5760.00
53.3452.9860.9860.9182.7088.9188.9188.4189.5688.9486.3486.7986.7486.5187.4778.31
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales GenMont Biotech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue GenMont Biotech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare GenMont Biotech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares GenMont Biotech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against GenMont Biotech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

GenMont Biotech stock margins

The GenMont Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GenMont Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GenMont Biotech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
68.27 %
30.21 %
38.87 %
Jan 1, 2019
66.34 %
22.17 %
16.59 %
Jan 1, 2020
66.23 %
23.68 %
18.72 %
Jan 1, 2021
69.95 %
33.53 %
26.44 %
Jan 1, 2022
69.66 %
16.33 %
15.46 %
Jan 1, 2023
66.41 %
2.20 %
10.37 %
Jan 1, 2024
61.80 %
10.41 %
14.86 %
Jan 1, 2025
62.72 %
14.39 %
14.26 %

GenMont Biotech Stock Revenue, EBIT, Earnings per Share

The GenMont Biotech earnings per share therefore indicates how much revenue GenMont Biotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
4.54 TWD
1.37 TWD
1.76 TWD
Jan 1, 2019
3.89 TWD
0.86 TWD
0.65 TWD
Jan 1, 2020
3.77 TWD
0.89 TWD
0.71 TWD
Jan 1, 2021
4.93 TWD
1.65 TWD
1.30 TWD
Jan 1, 2022
4.25 TWD
0.69 TWD
0.66 TWD
Jan 1, 2023
3.68 TWD
0.08 TWD
0.38 TWD
Jan 1, 2024
4.41 TWD
0.46 TWD
0.65 TWD
Jan 1, 2025
5.12 TWD
0.74 TWD
0.73 TWD

GenMont Biotech business model & stock analysis

GenMont Biotech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

GenMont Biotech historical P/E ratio, EBIT multiple, and P/S ratio

GenMont Biotech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

GenMont Biotech shares outstanding

The number of shares of GenMont Biotech was 78.31 M in 2025. This indicates how many shares GenMont Biotech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
89.56 M Stocks
Jan 1, 2019
88.94 M Stocks
Jan 1, 2020
86.34 M Stocks
Jan 1, 2021
86.79 M Stocks
Jan 1, 2022
86.74 M Stocks
Jan 1, 2023
86.51 M Stocks
Jan 1, 2024
87.47 M Stocks
Jan 1, 2025
78.31 M Stocks

GenMont Biotech stock splits

In GenMont Biotech's history, there have been no stock splits.

GenMont Biotech Dividend History

13 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.80TWDYTD—1×
Apr 8, 20260.80TWD 0.0%1/1
20250.80TWD↑ 60.0%1×
Mar 27, 20250.80TWD↑ 60.0%1/1
20240.50TWD↓ 28.6%1×
20230.70TWD↑ 22.8%1×
20210.57TWD↓ 28.8%1×
20200.80TWD↓ 46.7%1×
20191.50TWD↑ 200.0%1×
20130.50TWD↓ 50.0%1×
20121.00TWD↓ 50.0%1×
20112.00TWD↑ 120.0%1×

GenMont Biotech dividend history and estimates

In 2025, GenMont Biotech paid a dividend amounting to 0.80 TWD. Dividend means that GenMont Biotech distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2012
1.00 TWD
0.00 TWD
Jan 1, 2013
0.50 TWD
0.00 TWD
Jan 1, 2019
1.50 TWD
0.00 TWD
Jan 1, 2020
0.80 TWD
0.00 TWD
Jan 1, 2021
0.57 TWD
0.00 TWD
Jan 1, 2023
0.70 TWD
0.00 TWD
Jan 1, 2024
0.50 TWD
0.00 TWD
Jan 1, 2025
0.80 TWD
0.00 TWD

GenMont Biotech dividend payout ratio

In 2025, GenMont Biotech had a payout ratio of 109.53%. The payout ratio indicates the percentage of the company's profits that GenMont Biotech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
123.16 %
Jan 1, 2019
232.20 %
Jan 1, 2020
113.42 %
Jan 1, 2021
43.71 %
Jan 1, 2022
123.16 %
Jan 1, 2023
183.56 %
Jan 1, 2024
76.39 %
Jan 1, 2025
109.53 %
Price targets and forecasts for GenMont Biotech are not yet available.

GenMont Biotech shareholder structure

% Name
0.12244%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.02325%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.

GenMont Biotech Beneficial Ownership Filings (SEC 13D/G)

Free Float
93.1%
Float Shares
-
Shares Outstanding
-

GenMont Biotech Executives and Management Board

13 members · 11 % women

Management

WC

Weimin Chen

Chief Operating Officer

–
YC

Ms. Yujin Chen

Deputy General Manager · since 2008

–
ZH

Zhaotang Huang

Manager of Accounting

–
TY

Tianyou Ye

Assistant General Manager-Finance Division · since 2020

–

Board of Directors

GC

Mr. Gende Chen

Chairman of the Board · since 2005

4.19 M TWD
GH

Mr. Guojie Huang

Director

–
YL

Yixiong Lin

Director

–
DY

Mr. Dehui Yang

Director

–
CZ

Mr. Chuanzhen Zhuo

Director

–
ZG

Mr. Zhibin Gao

Independent Director

–

Frequently asked questions about GenMont Biotech

Converted at the current exchange rate, the GenMont Biotech share trades at 0.45 EUR (16.55 TWD).

No history available for GenMont Biotech.

The revenue cannot currently be calculated for GenMont Biotech.

The profit cannot currently be calculated for GenMont Biotech.

The P/E ratio cannot be calculated for GenMont Biotech at the moment.

The P/S cannot be calculated for GenMont Biotech currently.

The Eulerpool Quality Score for GenMont Biotech is 2/10.

The ISIN of GenMont Biotech is TW0003164000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of GenMont Biotech is 3164.TW. The ticker symbol is used to trade GenMont Biotech shares on the stock exchange.

Over the past 12 months, GenMont Biotech paid a dividend of 0.80 TWD . This corresponds to a dividend yield of about 4.83 %. For the coming 12 months, GenMont Biotech is expected to pay a dividend of 0.80 TWD.

The current dividend yield of GenMont Biotech is 4.83 %.

GenMont Biotech pays a dividend, distributed in the months of , , , .

GenMont Biotech paid dividends every year for the past 3 years.

For the upcoming 12 months, dividends amounting to 0.80 TWD are expected. This corresponds to a dividend yield of 4.83 %.

GenMont Biotech is assigned to the 'Health' sector.

To receive the latest dividend of GenMont Biotech from amounting to 0.8 TWD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, GenMont Biotech distributed 0.5 TWD as dividends.

The dividends of GenMont Biotech are distributed in TWD.

All fundamentals and in-depth analysis of GenMont Biotech

Our stock analysis for GenMont Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GenMont Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

GenMont Biotech Stock
GenMont Biotech Revenue→
GenMont Biotech Stock
GenMont Biotech Net Income→
GenMont Biotech Stock
GenMont Biotech P/E→
GenMont Biotech Stock
GenMont Biotech P/S→
GenMont Biotech Stock
GenMont Biotech EBIT→
GenMont Biotech Stock
GenMont Biotech Dividend→
GenMont Biotech Stock
GenMont Biotech Directors Dealings→
GenMont Biotech Stock
GenMont Biotech Stocks→
GenMont Biotech Stock
GenMont Biotech Market capitalization→
GenMont Biotech Stock
GenMont Biotech Debt→
GenMont Biotech Stock
GenMont Biotech Liabilities→
GenMont Biotech Stock
GenMont Biotech Equity→
GenMont Biotech Stock
GenMont Biotech AAQS→
GenMont Biotech Stock
GenMont Biotech Employees→
GenMont Biotech Stock
GenMont Biotech ROE→
GenMont Biotech Stock
GenMont Biotech ROA→
GenMont Biotech Stock
GenMont Biotech ROCE→
GenMont Biotech Stock
GenMont Biotech News→
GenMont Biotech Stock
GenMont Biotech Analyst Price Targets→

Health Stocks

Gennex LaboratoriesGenmab ASGenocea BiosciencesGeninusGenolutionGenincodeGenome&CompanyGenflow BiosciencesGenomedGenfitGenomics Bioscience & Technology CoGenexineAll Stocks A–Z →